Spots Global Cancer Trial Database for axatilimab
Every month we try and update this database with for axatilimab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors | NCT06320405 | Advanced Malign... Metastatic Mali... Recurrent Malig... Refractory Mali... | Axatilimab Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Paclitaxel Positron Emissi... Retifanlimab | 18 Years - | OHSU Knight Cancer Institute | |
A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors | NCT03238027 | Solid Tumor Metastatic Tumo... Locally Advance... Unresectable Ma... | Axatilimab Durvalumab | 18 Years - | Syndax Pharmaceuticals | |
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation | NCT05491226 | TNBC - Triple-N... Breast Cancer | Pembrolizumab Radiation Thera... Axatilimab | 18 Years - | Cedars-Sinai Medical Center | |
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation | NCT05491226 | TNBC - Triple-N... Breast Cancer | Pembrolizumab Radiation Thera... Axatilimab | 18 Years - | Cedars-Sinai Medical Center |